CD47 and non-small cell lung carcinoma: In the present study, we investigated the expression of CD47 in NSCLC in clinic, as well as the experimental settings; and explored the therapeutic potential of targeting CD47 with small interfering RNA (siRNA) and the underlying regulatory mechanisms, with specific focus on Cdc42, both in vitro and in vivo.